HUT56563A - Process for producing at 7-position heterosubstituted 5-alkyl-quinolonecarboxylic acids, as well as antibacterial agents and fodder additives - Google Patents

Process for producing at 7-position heterosubstituted 5-alkyl-quinolonecarboxylic acids, as well as antibacterial agents and fodder additives

Info

Publication number
HUT56563A
HUT56563A HU902055A HU205590A HUT56563A HU T56563 A HUT56563 A HU T56563A HU 902055 A HU902055 A HU 902055A HU 205590 A HU205590 A HU 205590A HU T56563 A HUT56563 A HU T56563A
Authority
HU
Hungary
Prior art keywords
heterosubstituted
alkyl
producing
well
antibacterial agents
Prior art date
Application number
HU902055A
Other languages
English (en)
Other versions
HU902055D0 (en
HU204811B (en
Inventor
Michael Schriewer
Klaus Grohe
Andreas Krebs
Uwe Petersen
Thomas Schenke
Ingo Haller
Karl Georg Metzger
Rainer Endermann
Hans-Joachim Zeiler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HU902055D0 publication Critical patent/HU902055D0/hu
Publication of HUT56563A publication Critical patent/HUT56563A/hu
Publication of HU204811B publication Critical patent/HU204811B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU902055A 1989-04-03 1990-04-03 Process for producing in 7-position heterosubstituted 5-alkylquinolonecarboxylic acids and antibacterial compositions comprising such compounds HU204811B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3910663A DE3910663A1 (de) 1989-04-03 1989-04-03 5-alkylchinoloncarbonsaeuren

Publications (3)

Publication Number Publication Date
HU902055D0 HU902055D0 (en) 1990-08-28
HUT56563A true HUT56563A (en) 1991-09-30
HU204811B HU204811B (en) 1992-02-28

Family

ID=6377683

Family Applications (2)

Application Number Title Priority Date Filing Date
HU912263A HUT58056A (en) 1989-04-03 1990-04-03 Process for producing quinolonecarboxylic acid derivatives
HU902055A HU204811B (en) 1989-04-03 1990-04-03 Process for producing in 7-position heterosubstituted 5-alkylquinolonecarboxylic acids and antibacterial compositions comprising such compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU912263A HUT58056A (en) 1989-04-03 1990-04-03 Process for producing quinolonecarboxylic acid derivatives

Country Status (16)

Country Link
EP (1) EP0391132A1 (hu)
JP (1) JP3046035B2 (hu)
KR (1) KR0156245B1 (hu)
CN (1) CN1035945C (hu)
AU (1) AU638005B2 (hu)
CA (1) CA2013449C (hu)
DD (1) DD298400A5 (hu)
DE (1) DE3910663A1 (hu)
FI (1) FI901615A0 (hu)
HU (2) HUT58056A (hu)
IL (1) IL93954A0 (hu)
NO (1) NO173547C (hu)
NZ (1) NZ233142A (hu)
PH (1) PH27364A (hu)
PT (1) PT93639A (hu)
ZA (1) ZA902510B (hu)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
DD285601A5 (de) * 1988-07-15 1990-12-19 Bayer Ag,De Verfahren zur herstellung von 7-(1-pyrrolidinyl)-3-chinolon- und naphthyridoncarbonsaeure-derivaten
US5241076A (en) * 1989-04-17 1993-08-31 Bayer Aktiengesellschaft 1,4-diazatricyclo [6.3.0.0]undecanes
US5177210A (en) * 1989-04-17 1993-01-05 Bayer Aktiengesellschaft Preparation of 2,7-diazabicyclo(3.3.0)octanes
EP0393424B1 (de) * 1989-04-17 1995-09-27 Bayer Ag Verfahren zur Herstellung von 2,7-Diazabicyclo(3.3.0)octanen
WO1992021659A1 (en) * 1991-05-28 1992-12-10 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative
DE4120646A1 (de) * 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
TW209865B (hu) * 1992-01-10 1993-07-21 Bayer Ag
KR960003611B1 (ko) * 1992-07-23 1996-03-20 재단법인 한국화학연구소 신규한 디아자비시클로 알켄 유도체 및 그의 제조방법
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
DE4234330A1 (de) * 1992-10-12 1994-04-14 Bayer Ag Chinoloncarbonsäuren
JP3268098B2 (ja) * 1992-12-25 2002-03-25 第一製薬株式会社 二環性環状アミン誘導体
AU4272793A (en) * 1993-04-24 1994-11-21 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
DE4329600A1 (de) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
DE4339134A1 (de) * 1993-11-16 1995-05-18 Bayer Ag 1-(2-Fluorcyclopropyl)-chinolon- und -naphthyridoncarbonsäure-Derivate
DE4408212A1 (de) * 1994-03-11 1995-09-14 Bayer Ag 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
CZ291251B6 (cs) * 1996-02-23 2003-01-15 Bayer Aktiengesellschaft Popřípadě substituované 8-kyan-1-cyklopropyl-7-(2,8-diazabicyklo-[4,3,0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarboxylové kyseliny a jejich deriváty, způsob jejich výroby, léčiva tyto látka obsahující a jejich pouľití
DE19633805A1 (de) * 1996-02-23 1997-08-28 Bayer Ag Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate
DE19652239A1 (de) 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
EP1551843A1 (en) * 2002-09-10 2005-07-13 Pfizer Products Inc. Diazabicyclic compounds useful in the treatment of cns and other disorders
WO2005026147A1 (ja) 2003-09-10 2005-03-24 Kyorin Pharmaceutical Co., Ltd. ７−（４−置換−３−シクロプロピルアミノメチル−１−ピロリジニル）キノロンカルボン酸誘導体
US8222407B2 (en) 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
CN101718743B (zh) * 2009-11-30 2013-03-20 宁波大学 一种混合导体致密扩散障型氧传感器的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522405A1 (de) * 1985-06-22 1987-01-02 Bayer Ag 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln
DE3543513A1 (de) * 1985-12-10 1987-06-11 Bayer Ag Enantiomerenreine 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
DE3702393A1 (de) * 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
US5563138A (en) * 1987-04-16 1996-10-08 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents

Also Published As

Publication number Publication date
CA2013449C (en) 2001-01-02
CN1046162A (zh) 1990-10-17
PH27364A (en) 1993-06-21
NO901274D0 (no) 1990-03-20
NO173547C (no) 1993-12-29
PT93639A (pt) 1990-11-20
CA2013449A1 (en) 1990-10-03
NO901274L (no) 1990-10-04
NO173547B (no) 1993-09-20
ZA902510B (en) 1991-01-30
KR900016186A (ko) 1990-11-12
EP0391132A1 (de) 1990-10-10
DE3910663A1 (de) 1990-10-04
AU5231790A (en) 1990-10-04
JPH02289583A (ja) 1990-11-29
HUT58056A (en) 1992-01-28
HU902055D0 (en) 1990-08-28
CN1035945C (zh) 1997-09-24
HU204811B (en) 1992-02-28
DD298400A5 (de) 1992-02-20
NZ233142A (en) 1992-09-25
AU638005B2 (en) 1993-06-17
IL93954A0 (en) 1990-12-23
FI901615A0 (fi) 1990-03-30
JP3046035B2 (ja) 2000-05-29
KR0156245B1 (ko) 1998-11-16
HU912263D0 (en) 1991-12-30

Similar Documents

Publication Publication Date Title
HUT56563A (en) Process for producing at 7-position heterosubstituted 5-alkyl-quinolonecarboxylic acids, as well as antibacterial agents and fodder additives
HU904961D0 (en) Process for producing quinoline derivatives
HUT59558A (en) New 5-chloro-quinoline-8-oxy-alkane-carboxylic acid derivatives, process for producing and utilizing them as antidotum
GB2191776B (en) 1, 4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same
HU900038D0 (en) Harvesting machine for maize
HUT45498A (en) Process for producing new, substituted anilide derivatives
HUT47287A (en) Process for producing 3,4-dihydro-5h-2,3-benzodiazepine derivatives
HUT53086A (en) Process for producing new, substituted quinoline derivatives
HUT57790A (en) Process for producing deoxyfluoronucleoside derivatives
EP0357017A3 (en) Improved coagulating process for filaments
AU7036291A (en) Animal feed block composition
HUT46667A (en) Process for producing new, substituted anilide derivatives
HUT53876A (en) Improved process for producing guanidine derivatives
HU903908D0 (en) Process for producing new r(-)-3-quinuclidinole derivatives
HU907221D0 (en) Process for producing cepheme derivatives
HU906520D0 (en) Process for producing diaza-bicycloamine derivatives
HUT53773A (en) Antidotums containing substituted 1,8-naphtiridine derivatives as aktive components and process for producing the active components
HUT58042A (en) Process for producing tetrahydronaphthalene derivatives
HU9200020D0 (en) Process for producing 2,4,6 trifluoro-triazine
HU9201796D0 (en) Method for raising and/or fattening pigs, method for manufacturing humanfood products as well as fodder mixture
GB8720971D0 (en) Cutter for farm machine
HUT53898A (en) Process for producing 2,4-diamino-6-piperidinyl-3-n-oxide
EP0432815A3 (en) An agricultural machine
GB9012539D0 (en) An agricultural machine
HUT53884A (en) Process for producing 1-aryl-sulfonyl-pirrolidine-2-thion- and 1-arylsulfonyl-piperidine-2-thion derivatives

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee